ATE381575T1 - Veränderte borrelia burgdorferi ospa - Google Patents

Veränderte borrelia burgdorferi ospa

Info

Publication number
ATE381575T1
ATE381575T1 AT01964163T AT01964163T ATE381575T1 AT E381575 T1 ATE381575 T1 AT E381575T1 AT 01964163 T AT01964163 T AT 01964163T AT 01964163 T AT01964163 T AT 01964163T AT E381575 T1 ATE381575 T1 AT E381575T1
Authority
AT
Austria
Prior art keywords
ospa
modified
alteration
borrelia burgdorferi
ospa polypeptide
Prior art date
Application number
AT01964163T
Other languages
English (en)
Inventor
Benjamin Luft
John Dunn
Catherine I Lawson
Shohei Koide
Original Assignee
Univ New York State Res Found
Brookhaven Sciences Ass Llc
Univ Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found, Brookhaven Sciences Ass Llc, Univ Rochester filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of ATE381575T1 publication Critical patent/ATE381575T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01964163T 2000-08-18 2001-08-17 Veränderte borrelia burgdorferi ospa ATE381575T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22648400P 2000-08-18 2000-08-18

Publications (1)

Publication Number Publication Date
ATE381575T1 true ATE381575T1 (de) 2008-01-15

Family

ID=22849087

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01964163T ATE381575T1 (de) 2000-08-18 2001-08-17 Veränderte borrelia burgdorferi ospa

Country Status (9)

Country Link
US (3) US20040023325A1 (de)
EP (1) EP1311540B1 (de)
AT (1) ATE381575T1 (de)
AU (1) AU2001285049A1 (de)
DE (1) DE60131982T2 (de)
DK (1) DK1311540T3 (de)
ES (1) ES2298249T3 (de)
PT (1) PT1311540E (de)
WO (1) WO2002016421A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7008625B2 (en) * 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
ATE381575T1 (de) 2000-08-18 2008-01-15 Univ New York State Res Found Veränderte borrelia burgdorferi ospa
US20110262475A1 (en) * 2008-05-02 2011-10-27 Earnhart Christopher G Lyme disease vaccine
AU2011252844B2 (en) * 2010-05-14 2014-07-03 Baxalta GmbH Chimeric OspA genes, proteins, and methods of use thereof
WO2013067448A2 (en) 2011-11-03 2013-05-10 Vca Antech Inc. Compositions and methods to detect various infectious organisms
US8986704B2 (en) * 2012-07-06 2015-03-24 Valneva Austria Gmbh Mutant fragments of OspA and methods and uses relating thereto
AU2013293448A1 (en) 2012-07-27 2015-02-05 Baxalta GmbH Compositions comprising chimeric OspA molecules and methods of use thereof
HUE043779T2 (hu) 2014-01-09 2019-09-30 Valneva Austria Gmbh Az OspA mutáns fragmensei, valamint az ezzel kapcsolatos módszerek és alkalmazások
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US12018054B2 (en) 2017-04-13 2024-06-25 Valneva Austria Gmbh Multivalent OspA polypeptides and methods and uses relating thereto
EP3773698A1 (de) 2018-04-03 2021-02-17 Sanofi Ferritinproteine
WO2019195314A2 (en) 2018-04-03 2019-10-10 Sanofi Antigenic epstein barr virus polypeptides
JP7614841B2 (ja) 2018-04-03 2025-01-16 サノフイ 抗原性呼吸器合胞体ウイルスポリペプチド
KR20210018205A (ko) * 2018-04-03 2021-02-17 사노피 항원성 OspA 폴리펩타이드
US10749235B2 (en) 2018-09-07 2020-08-18 International Business Machines Corporation Well thermalized microstrip formation for flexible cryogenic microwave lines in quantum applications
EP4132950A1 (de) 2020-04-09 2023-02-15 Valneva Austria GmbH Zusammensetzungen mit drei ospa-fusionsproteinen zur medizinischen verwendung
WO2026080379A1 (en) * 2024-10-07 2026-04-16 Modernatx, Inc. Lyme disease mrna vaccines

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US5777095A (en) * 1988-10-24 1998-07-07 Symbicom Aktiebolag Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
US5246844A (en) 1991-10-22 1993-09-21 Board Of Regents, The University Of Texas System Virulence associated proteins in borrelia burgdorferi (bb)
DE4015911A1 (de) 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
DK0506868T4 (da) 1989-12-22 2004-04-26 Mikrogen Molekularbiol Entw Immunologisk aktive proteiner fra Borrelia burgdorferi, tilhørende testkits og vaccine
US5217872A (en) * 1990-02-27 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of borrelia burgdorferi antigens
JPH05501113A (ja) 1990-03-05 1993-03-04 アメリカ合衆国 ボレリア　ブルグドルフェリの抗原性タンパク質
US5470712A (en) * 1990-03-05 1995-11-28 Us Health Antigenic proteins of Borrelia burgdorferi
CA2084413A1 (en) * 1990-06-15 1991-12-16 Richard A. Flavell Compositions and methods for the prevention and diagnosis of lyme disease
EP1016416A3 (de) 1990-07-06 2002-10-23 Wyeth Impfstoff gegen die Lyme-Krankheit und Modell zur Überwachung der Impfstoffwirksamkeit
CA2057536C (en) 1990-12-21 1999-10-26 John J. Dunn Cloning and expression of borrelia lipoproteins
US6221363B1 (en) 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
US6113914A (en) 1991-08-15 2000-09-05 Smithkline Beecham Biologicals (S.A.) Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
PT100980B (pt) 1991-10-18 1999-07-30 Connaught Lab Proteinas recombinantes de borrelia, seu processo de producao, vacina contra infeccao por borrelia e agente de imunodiagnostico para a sua deteccao
ES2194010T3 (es) 1991-10-22 2003-11-16 Symbicom Ab Mejoras en el diagnostico y profilaxis de la borrelia burgdorferi.
CA2123121A1 (en) 1991-11-12 1993-05-27 Anthony C. Caputa Recombinant vaccine against lyme disease
EP0686265A4 (de) 1993-02-26 2001-08-22 Cambridge Biotech Corp Verfahren zum induzieren von immunität gegen die lyme-krankheit und ein kolorimetrischer test auf borreliazide aktivität von antisera
AU6366894A (en) 1993-03-11 1994-09-26 Regents Of The University Of California, The Methods, compositions, and kits for diagnosing lyme disease
FI955150A7 (fi) 1993-04-29 1995-12-28 Baxter Ag OspC-antigeenirokotteiden immunogeenisia formulaatioita lyymisairauden ehkäisyyn ja hoitoon ja rekombinanttimenetelmiä antigeenien valmistam iseksi
US6248562B1 (en) * 1993-11-01 2001-06-19 Research Foundation State University Of New York Chimeric proteins comprising borrelia polypeptides and uses therefor
US7008625B2 (en) * 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
AU8127494A (en) * 1993-11-01 1995-05-23 Associated Universities, Inc. Chimeric proteins comprising borrelia polypeptides: uses therefor
US5620862A (en) * 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease
US6251405B1 (en) 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
PT832093E (pt) 1995-06-07 2006-12-29 Sanofi Pasteur Inc Expressão de lipoproteínas
DE69718903T2 (de) 1996-05-02 2003-12-04 Dakocytomation Denmark A/S, Glostrup Verwendung von aus osp-c abgeleiteten peptidefragmenten für diagnostische methoden
AUPO069996A0 (en) 1996-06-27 1996-07-18 Australian National University, The Manipulation of plant cellulose
DE19740735A1 (de) 1997-09-16 1999-03-18 Max Planck Gesellschaft Arzneimittel zur Therapie einer manifesten Lyme-Borreliose
EP1100922B1 (de) * 1998-07-31 2008-02-20 Gundersen Lutheran Medical Foundation, Inc. Verwendungen eines borreliaziden epitops des aussermembranproteins c von borrelia burgdorferi (ospc) als impstoff
ATE381575T1 (de) * 2000-08-18 2008-01-15 Univ New York State Res Found Veränderte borrelia burgdorferi ospa

Also Published As

Publication number Publication date
WO2002016421A3 (en) 2003-03-06
US20090326200A1 (en) 2009-12-31
EP1311540A2 (de) 2003-05-21
DE60131982D1 (de) 2008-01-31
WO2002016421A8 (en) 2002-07-11
US20140030285A1 (en) 2014-01-30
PT1311540E (pt) 2008-03-20
AU2001285049A1 (en) 2002-03-04
DE60131982T2 (de) 2008-12-11
EP1311540B1 (de) 2007-12-19
WO2002016421A9 (en) 2003-09-04
US20040023325A1 (en) 2004-02-05
WO2002016421A2 (en) 2002-02-28
DK1311540T3 (da) 2008-04-28
US8680236B2 (en) 2014-03-25
US8992936B2 (en) 2015-03-31
ES2298249T3 (es) 2008-05-16

Similar Documents

Publication Publication Date Title
ATE381575T1 (de) Veränderte borrelia burgdorferi ospa
ATE340262T1 (de) Gruppen von borrelia burgdorferi, die lyme krankheit verursachen
ES2535084T3 (es) Proteínas N-glicosiladas recombinantes procedentes de células procariotas
EP2305312A3 (de) Neumodulierung und Glykokonjugation von Follitropin (FSH)
BR0113286A (pt) Pirazóis substituìdos
WO2001064835A8 (en) Novel nucleic acids and polypeptides
CY1108602T1 (el) Μεθοδος καθαρισμου της fsh
ATE312843T1 (de) Neues cyclosporin mit verbesserter wirkung
EP2338333A3 (de) Glycopegylierungsverfahren und durch die Verfahren hergestellte Proteine/Peptide
ATE323095T1 (de) 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
CY1108221T1 (el) Μεθοδος για την αναπαραγωγη πλευρομουτιλινων
ATE321853T1 (de) Humanische pellino-polypeptide
TR200101783T2 (tr) Saydam transdermal nikotin iletme düzenekleri.
DE60042816D1 (de) T-helferzellen-epitope
DK1538162T3 (da) Sammensætninger til ændring af slimsekretion
PT1232183E (pt) Peptidos possuindo actividade anti-angiogenica
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
EP1865062A3 (de) Verändertes OspA der Borrelia burgdorferi
NO20021573D0 (no) Tverrbundne kopolymerer basert på ikke-tverrbundne polykarboksylkopolymerer
ATE332902T1 (de) 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
ATE554793T1 (de) Konjugat
EA200500544A1 (ru) Игровой аппарат
WO2003014144A3 (en) Molecule
Priyamvada Rukogi Nahin Radhika
NO20014497L (no) Konvertibel, flerfunksjonell katamaran

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1311540

Country of ref document: EP